FDA Inspection 1204407 — e+ Oncologics Louisiana LLC
The FDA completed an inspection of e+ Oncologics Louisiana LLC on March 28, 2023 in New Iberia, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 28, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Iberia, LA (United States)